<DOC>
	<DOCNO>NCT01201720</DOCNO>
	<brief_summary>The purpose study evaluate effect plasma exchange 5 % albumin albumin functional capacity , cardiocirculatory , renal cerebral function cirrhotic patient `` acute-on-chronic liver failure '' .</brief_summary>
	<brief_title>Effects Plasma Exchange Functional Capacity Serum Albumin , Circulatory Dysfunction , Renal Cerebral Function Cirrhotic Patients With `` Acute-on-chronic Liver Failure ''</brief_title>
	<detailed_description>The purpose study evaluate effect plasma exchange 5 % albumin albumin functional capacity , cardiocirculatory , renal cerebral function cirrhotic patient `` acute-on-chronic liver failure '' , renal disfunction , cerebral disfunction , inflamtory response</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Liver Failure</mesh_term>
	<mesh_term>End Stage Liver Disease</mesh_term>
	<mesh_term>Acute-On-Chronic Liver Failure</mesh_term>
	<criteria>Age 18 80 year old Hepatic cirrhosis diagnose biopsy clinical , analytic ultra sound data . acute chronic liver failure : define acute deterioration hepatic function produce 24 week jaundice ( total serum bilirubin ≥ 5 mg/dl ) hepatic encephalopathy ( ≥ grade 2 ) and/or renal insufficiency ( serum creatinine ≥ 2 mg/dl ) Neoplasm disease include hepatocarcinoma exceed Milan criterion ( 1 tumour &gt; 5cm , 3 tumour &lt; 3 cm ) Active bacterial fungal infection hemodynamic instability require utilization vasoactive drug moderate dose ( &gt; 0,5 μg/Kg/min noradrenaline ) Structural moderate severe cardiopathy ( Cardiac Index &lt; 2l/min/m2 ) Chronic renal insufficiency treatment haemodialysis Chronic moderate severe pulmonary disease ( maximum expiratory volume second &lt; 50 % ) Active transplant human immunodeficiency virus infection Pregnancy lactation Acute respiratory distress syndrome ( P02/Fi02 &lt; 200mm Hg ) acute lung injury ( P02/Fi02 &lt; 300mm Hg ) Hemodynamic instability ( &gt; 0,5 μg/Kg/min noradrenaline ) Bleeding digestive tract previous 72h treatment Severe coagulopathy : INR ≥ 3.0 ( Quick ≤ 20 % ) and/or platelet &lt; 30000//mm3 Extrahepatic cholestasis Hepatobiliary surgery last 6 month ( except laparoscopic Cholecystectomy ) Concentrations bilirubin ≥ 5mg/dl period 4 week previous inclusion Concomitant participation clinical trial Drug addiction Mental status allow patient understand trial , exception hepatic encephalopathy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>cirrhosis</keyword>
	<keyword>cirrhotic patient acute chronic liver failure</keyword>
</DOC>